Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
It is critical to seek potential alternative treatments for H1N1 infections by inhibiting neuraminidase-1 enzyme. One of the viable options for inhibiting the activity of neuraminidase- 1 is peptide drug design. In order to increase peptide stability, cyclization is necessary to prevent its digestio...
Saved in:
Main Authors: | Tambunan Usman Sumo Friend, Parikesit Arli Aditya, Dephinto Yonaniko, Sipahutar Feimmy Ruth Pratiwi |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0015/acph-2014-0015.xml?format=INT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking
by: Maheswata Sahoo, et al.
Published: (2016-09-01) -
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01) -
Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening
by: Jungan Zhang, et al.
Published: (2025-01-01) -
Importance of OsRac1 in Signalling of Pigm-1 Mediated Resistance to Rice Blast Disease
by: Dewei Yang, et al.
Published: (2025-01-01) -
DICER1: The Argonaute Endonuclease Family Member and Its Role in Pediatric and Youth Pathology
by: Consolato M. Sergi, et al.
Published: (2025-01-01)